Mbm Wealth Consultants, LLC Abb Vie Inc. Transaction History

Mbm Wealth Consultants, LLC

$324 Million
Q1 2025

A detailed history of Mbm Wealth Consultants, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Mbm Wealth Consultants, LLC holds 11,592 shares of ABBV stock, worth $2.28 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares

11,592

Previous 11,346 2.17%

Holding current value

$2.28 Million

Previous $2.02 Million 20.44%

% of portfolio

0.75%

Previous 0.63%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 28, 2025	BUY	$169.2 - $216.66 $41,623 - $53,298	246 Added 2.17%	11,592 $2.43 Million
Q4 2024 Jan 17, 2025	BUY	$164.99 - $203.87 $13,694 - $16,921	83 Added 0.74%	11,346 $2.02 Million
Q3 2024 Oct 07, 2024	SELL	$163.84 - $199.33 $21,790 - $26,510	-133 Reduced 1.17%	11,263 $2.22 Million
Q2 2024 Jul 30, 2024	BUY	$154.79 - $180.76 $25,230 - $29,463	163 Added 1.45%	11,396 $1.95 Million
Q1 2024 Apr 18, 2024	SELL	$159.82 - $182.1 $10,867 - $12,382	-68 Reduced 0.6%	11,233 $2.05 Million
Q4 2023 Jan 30, 2024	SELL	$137.6 - $154.97 $22,704 - $25,570	-165 Reduced 1.44%	11,301 $1.75 Million
Q3 2023 Oct 19, 2023	BUY	$133.59 - $154.65 $14,427 - $16,702	108 Added 0.95%	11,466 $1.71 Million
Q2 2023 Jul 24, 2023	BUY	$132.51 - $164.9 $97,659 - $121,531	737 Added 6.94%	11,358 $1.53 Million
Q4 2022 Feb 15, 2023	BUY	$138.31 - $165.87 $13,001 - $15,591	94 Added 0.89%	10,621 $1.73 Million
Q3 2022 Oct 24, 2022	BUY	$134.21 - $153.93 $63,347 - $72,654	472 Added 4.69%	10,527 $1.46 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $40,873 - $51,963	-297 Reduced 2.87%	10,055 $1.54 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $2,639 - $3,275	20 Added 0.19%	10,352 $1.68 Million
Q4 2021 Feb 15, 2022	BUY	$107.43 - $135.93 $1,933 - $2,446	18 Added 0.17%	10,332 $1.4 Million
Q3 2021 Nov 16, 2021	SELL	$106.4 - $120.78 $1,489 - $1,690	-14 Reduced 0.14%	10,314 $1.11 Million
Q2 2021 Aug 13, 2021	SELL	$105.21 - $117.21 $3,577 - $3,985	-34 Reduced 0.33%	10,328 $1.16 Million
Q1 2021 May 10, 2021	SELL	$102.3 - $112.62 $49,922 - $54,958	-488 Reduced 4.5%	10,362 $1.12 Million
Q4 2020 Feb 09, 2021	SELL	$80.49 - $108.67 $2,978 - $4,020	-37 Reduced 0.34%	10,850 $1.16 Million
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $10,910 - $12,805	-127 Reduced 1.15%	10,887 $953,000
Q2 2020 Aug 07, 2020	SELL	$73.37 - $98.18 $351,222 - $469,987	-4,787 Reduced 30.3%	11,014 $1.08 Million
Q1 2020 May 13, 2020	SELL	$64.5 - $97.79 $10,126 - $15,353	-157 Reduced 0.98%	15,801 $1.25 Million
Q4 2019 Feb 11, 2020	SELL	$72.13 - $90.25 $95,644 - $119,671	-1,326 Reduced 7.67%	15,958 $1.41 Million
Q3 2019 Oct 30, 2019	BUY	$62.98 - $75.72 $12,218 - $14,689	194 Added 1.14%	17,284 $1.31 Million
Q2 2019 Jul 30, 2019	BUY	$65.7 - $83.98 $27,199 - $34,767	414 Added 2.48%	17,090 $1.26 Million
Q1 2019 Apr 25, 2019	BUY	$77.14 - $90.79 $26,381 - $31,050	342 Added 2.09%	16,676 $1.34 Million
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $1.27 Million - $1.57 Million	16,334 New	16,334 $1.51 Million

Others Institutions Holding ABBV

# of Institutions

4,253

Shares Held

1.27B

Call Options Held

16.6M

Put Options Held

15M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $347B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mbm Wealth Consultants, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mbm Wealth Consultants, LLC with notifications on news.

Account

Mbm Wealth Consultants, LLC Abb Vie Inc. Transaction History